Fri, February 14, 2020

David Risinger Maintained (TEVA) at Sell with Increased Target to $13 on, Feb 14th, 2020

David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Increased Target from $8 to $13 on, Feb 14th, 2020.

David has made no other calls on TEVA in the last 4 months.



There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $15 on, Wednesday, February 12th, 2020
  • Sel Hardy of "CFRA" Maintained at Hold with Increased Target to $13 on, Wednesday, February 12th, 2020
  • Jacob Hughes of "Wells Fargo" Maintained at Hold with Increased Target to $10 on, Wednesday, January 22nd, 2020
  • Chris Schott of "JP Morgan" Upgraded from Sell to Hold on, Tuesday, November 12th, 2019
  • David Amsellem of "Piper Sandler" Maintained at Hold with Increased Target to $7 on, Friday, November 8th, 2019


These are the ratings of the 2 analyists that currently disagree with David


  • Jason Gerberry of "B of A Securities" Maintained at Sell with Increased Target to $11 on, Thursday, February 13th, 2020
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $16 on, Thursday, February 13th, 2020